Cerebral Hypoperfusion Intensity Ratio Is Linked to Progressive Early Edema Formation.

brain edema collateral circulation ischemic stroke perfusion imaging thrombectomy

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
23 Apr 2022
Historique:
received: 12 03 2022
revised: 09 04 2022
accepted: 16 04 2022
entrez: 14 5 2022
pubmed: 15 5 2022
medline: 15 5 2022
Statut: epublish

Résumé

The hypoperfusion intensity ratio (HIR) is associated with collateral status and reflects the impaired microperfusion of brain tissue in patients with acute ischemic stroke and large vessel occlusion (AIS-LVO). As a deterioration in cerebral blood flow is associated with brain edema, we aimed to investigate whether HIR is correlated with the early edema progression rate (EPR) determined by the ischemic net water uptake (NWU) in a multicenter retrospective analysis of AIS-LVO patients anticipated for thrombectomy treatment. HIR was automatically calculated as the ratio of time-to-maximum (TMax) > 10 s/(TMax) > 6 s. HIRs < 0.4 were regarded as favorable (HIR+) and ≥0.4 as unfavorable (HIR−). Quantitative ischemic lesion NWU was delineated on baseline NCCT images and EPR was calculated as the ratio of NWU/time from symptom onset to imaging. Multivariable regression analysis was used to assess the association of HIR with EPR. This study included 731 patients. HIR+ patients exhibited a reduced median NWU upon admission CT (4% (IQR: 2.1−7.6) versus 8.2% (6−10.4); p < 0.001) and less median EPR (0.016%/h (IQR: 0.007−0.04) versus 0.044%/h (IQR: 0.021−0.089; p < 0.001) compared to HIR− patients. Multivariable regression showed that HIR+ (β: 0.53, SE: 0.02; p = 0.003) and presentation of the National Institutes of Health Stroke Scale (β: 0.2, SE: 0.0006; p = 0.001) were independently associated with EPR. In conclusion, favorable HIR was associated with lower early edema progression and decreased ischemic edema formation on baseline NCCT.

Identifiants

pubmed: 35566500
pii: jcm11092373
doi: 10.3390/jcm11092373
pmc: PMC9105689
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : 411621970

Références

J Clin Med. 2021 Apr 26;10(9):
pubmed: 33925888
Brain. 2019 May 1;142(5):1399-1407
pubmed: 30859191
Stroke. 2019 Apr;50(4):917-922
pubmed: 30841821
Stroke. 2018 Aug;49(8):1906-1912
pubmed: 29976584
AJNR Am J Neuroradiol. 2001 Sep;22(8):1534-42
pubmed: 11559501
J Neurol Neurosurg Psychiatry. 2008 Jun;79(6):625-9
pubmed: 18077482
Invest Radiol. 2019 May;54(5):282-287
pubmed: 30562271
Ann Neurol. 2016 Dec;80(6):924-934
pubmed: 28001316
Curr Opin Neurol. 2015 Feb;28(1):10-5
pubmed: 25514251
Stroke. 2003 Sep;34(9):2279-84
pubmed: 12881609
Stroke. 2014 Apr;45(4):1018-23
pubmed: 24595591
Ann Neurol. 2007 Jun;61(6):533-43
pubmed: 17431875
J Neurointerv Surg. 2020 Aug;12(8):747-752
pubmed: 31772043
Stroke. 2021 May;52(5):1761-1767
pubmed: 33682452
J Cereb Blood Flow Metab. 2021 Aug;41(8):2067-2075
pubmed: 33557694
Radiology. 2018 Feb;286(2):731
pubmed: 29356644
J Neurointerv Surg. 2021 May;13(5):421-425
pubmed: 32554693
Eur J Neurol. 2020 May;27(5):864-870
pubmed: 32068938
Invest Radiol. 2018 Apr;53(4):207-213
pubmed: 29200013
Stroke. 2019 Dec;50(12):3424-3430
pubmed: 31665994
Top Magn Reson Imaging. 2021 Aug 1;30(4):181-186
pubmed: 34397967
AJNR Am J Neuroradiol. 2015 Feb;36(2):289-94
pubmed: 25324493
Curr Opin Neurol. 2015 Feb;28(1):1-3
pubmed: 25490198
Ann Neurol. 2018 Oct;84(4):616-620
pubmed: 30168180
Neuroimaging Clin N Am. 2005 Aug;15(3):553-73, x
pubmed: 16360589

Auteurs

Noel van Horn (N)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.

Gabriel Broocks (G)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.

Reza Kabiri (R)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.

Michel C Kraemer (MC)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.

Soren Christensen (S)

Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA.

Michael Mlynash (M)

Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA.

Lukas Meyer (L)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.

Maarten G Lansberg (MG)

Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA.

Gregory W Albers (GW)

Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA.

Peter Sporns (P)

Department of Diagnostic and Interventional Neuroradiology, University Hospital Basel, 4031 Basel, Switzerland.

Adrien Guenego (A)

Department of Interventional Neuroradiology, Erasme University Hospital, 1070 Brussels, Belgium.

Jens Fiehler (J)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.

Max Wintermark (M)

Department of Radiology, Stanford University School of Medicine, Stanford, CA 94305, USA.

Jeremy J Heit (JJ)

Department of Radiology, Stanford University School of Medicine, Stanford, CA 94305, USA.

Tobias D Faizy (TD)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.

Classifications MeSH